Page last updated: 2024-08-24

irinotecan and Cafe-au-Lait Spots with Pulmonic Stenosis

irinotecan has been researched along with Cafe-au-Lait Spots with Pulmonic Stenosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Durbin, AD; Ki, DH; Look, AT; Oppel, F	1
Bhardwaj, RD; Nakaji, P; Ponce, FA; Rosenfeld, A; Xu, DS	1
Abe, N; Abe, S; Aoto, K; Kawana, S; Murakami, F; Ohtake, T; Okano, M; Suzuki, O; Tachibana, K; Takenoshita, S; Tasaki, K	1

Reviews

1 review(s) available for irinotecan and Cafe-au-Lait Spots with Pulmonic Stenosis

Article	Year
[A Case of Primary Poorly Differentiated/Small Cell Carcinoma of the Breast in a Patient with Von Recklinghausen's Disease]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Irinotecan; Middle Aged; Neurofibromatosis 1	2016

Article

Year

[A Case of Primary Poorly Differentiated/Small Cell Carcinoma of the Breast in a Patient with Von Recklinghausen's Disease].

Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Irinotecan; Middle Aged; Neurofibromatosis 1

2016

Other Studies

2 other study(ies) available for irinotecan and Cafe-au-Lait Spots with Pulmonic Stenosis

Article	Year
Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumors. Oncogene, 2019, Volume: 38, Issue:39 Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Benzamides; Cell Cycle Proteins; Disease Models, Animal; Humans; Irinotecan; Morpholines; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nerves; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Topoisomerase I Inhibitors; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays; Zebrafish	2019
Cerebral peduncle tumor ablated by novel 3-mm laser tip. Stereotactic and functional neurosurgery, 2015, Volume: 93, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Camptothecin; Cerebral Peduncle; Child; Combined Modality Therapy; Dacarbazine; Glioma; Humans; Infratentorial Neoplasms; Irinotecan; Laser Therapy; Male; Neoplasms, Multiple Primary; Neurofibromatosis 1; Neuroimaging; Optic Nerve Glioma; Supratentorial Neoplasms; Temozolomide	2015

Article

Year

Mechanisms underlying synergy between DNA topoisomerase I-targeted drugs and mTOR kinase inhibitors in NF1-associated malignant peripheral nerve sheath tumors.

Oncogene, 2019, Volume: 38, Issue:39

Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Benzamides; Cell Cycle Proteins; Disease Models, Animal; Humans; Irinotecan; Morpholines; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nerves; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Topoisomerase I Inhibitors; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays; Zebrafish

2019

Cerebral peduncle tumor ablated by novel 3-mm laser tip.

Stereotactic and functional neurosurgery, 2015, Volume: 93, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Camptothecin; Cerebral Peduncle; Child; Combined Modality Therapy; Dacarbazine; Glioma; Humans; Infratentorial Neoplasms; Irinotecan; Laser Therapy; Male; Neoplasms, Multiple Primary; Neurofibromatosis 1; Neuroimaging; Optic Nerve Glioma; Supratentorial Neoplasms; Temozolomide

2015